1. Systemic isotretinoin therapy and central macular and choroidal thicknesses in acne vulgaris: is there any association?
- Author
-
Dehghani A, Kargar S, Faghihi G, Adibi N, Noorshargh P, Dehghani S, Pourazizi M, and Abtahi-Naeini B
- Subjects
- Female, Humans, Adolescent, Young Adult, Adult, Choroid diagnostic imaging, Fovea Centralis, Tomography, Optical Coherence methods, Isotretinoin adverse effects, Acne Vulgaris drug therapy
- Abstract
Purpose: To investigate the effect of oral isotretinoin therapy on central macular thickness (CMT) thickness and choroidal thickness (CT) using optical coherence tomography (OCT)., Methods: CT and CMT thickness of 43 eyes were evaluated at baseline, the third, and sixth month of isotretinoin therapy by spectral-domain OCT. For assessment of CT, OCT measurements were obtained at the fovea with six additional measurements at adjacent locations (at 500-1000 µm temporal to the fovea and 500-1000 µm nasal to the fovea)., Results: Forty-three eyes from 43 patients with acne vulgaris, including 33 females (76.7%), who had a mean age of 24.81 ± 6.60 years, completed the study. The mean CMT was 231.49 ± 19.52 at the baseline and significantly decreased to 229.0 ± 19.57 ( p = 0.02) and 229.28 ± 18.83 after three and six months, respectively ( p < 0.03). The change in the macular thicknesses measured at four quadrants and choroidal thicknesses were not statistically significant during the study ( p > 0.05)., Conclusion: The result of our study demonstrated choroidal thickness change is not significant in patients with acne vulgaris after systemic isotretinoin therapy during six months of follow-up. The decreased CMT amount was 2.2 microns; even if statistically significant, this amount is clinically insignificant.
- Published
- 2023
- Full Text
- View/download PDF